Research in Texas
- 1 of 3
- next ›
Biopharmaceutical research companies are conduct- ing or have conducted more than 8,200 clinical trials of new medicines in collaboration with the state’s clinical research centers, university medical schools and hospitals (1999 to present).
Of the more than 8,200 clinical trials, more than 4,300 target the nation’s six most debilitating chronic diseases—asthma, cancer, diabetes, heart disease, mental illnesses and stroke.